Home Applications 209279 Application 209279
Type NDA
Sponsor ACTELION PHARMS Application Products# Product, Drug, Ingredient table Product Drug Ingredient Form Strength Reference drug Reference standard 001 TRACLEER BOSENTAN TABLET, FOR SUSPENSION;ORAL 32MG Yes Yes
Source provenance: Browse the complete Orange Book source catalog · source snapshot 44 .
Orange Book products# Current product rows page 1 of 1 · 1 matching rows.
Application-product, Trade name, Ingredient table Application-product Trade name Ingredient Strength Dosage form / route TE codes RLD / RS Approval date N209279-001 TRACLEER BOSENTAN 32MG TABLET, FOR SUSPENSION / ORAL AB RLD, RS 2017-09-05
Therapeutic equivalence codes# Current TE-code rows page 1 of 1 · 1 matching rows.
Application-product, TE code table Application-product TE code N209279-001 AB
Orange Book patents# Current patent rows page 1 of 1 · 2 matching rows.
Application-product, Patent, Expiration table Application-product Patent Expiration Use code Coverage / status Submission date N209279-001 8309126 2026-05-15 Drug product 2017-10-03 N209279-001 7959945 2027-12-28 Drug product 2017-10-03
Observed Orange Book product history# Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
Product history page 2 of 2 · 44 observed states.
Captured, Edition, Application-product table Captured Edition Application-product Trade name Strength Dosage form / route Product TE source text RLD / RS Approval date Source SHA-256 2022-10-28 04:53 UTC 2022-10 N209279-001 TRACLEER 32MG TABLET, FOR SUSPENSION / ORAL RLD, RS 2017-09-05 f41ea6bd6efb…2022-09-29 23:25 UTC 2022-09 N209279-001 TRACLEER 32MG TABLET, FOR SUSPENSION / ORAL RLD, RS 2017-09-05 e64feba35796…2022-07-09 03:26 UTC · 3 captures of this ZIP 2022-07 N209279-001 TRACLEER 32MG TABLET, FOR SUSPENSION / ORAL RLD, RS 2017-09-05 cb3db0bc1861…2026-07-26 02:55 UTC · 3 captures of this ZIP 2026-06 N209279-001 TRACLEER 32MG TABLET, FOR SUSPENSION / ORAL AB RLD, RS 2017-09-05 a50c72e98297…
Observed Orange Book normalized TE history# Observed Orange Book patent history# Patent history page 1 of 3 · 88 observed states.
Captured, Edition, Application-product table Captured Edition Application-product Patent Expiration Use code Coverage / status Submission date Source SHA-256 2026-10-15 13:18:30 2026-09 N209279-001 8309126 2026-05-15 Drug product 2017-10-03 c2088c7a36db…2026-10-15 13:18:30 2026-09 N209279-001 7959945 2027-12-28 Drug product 2017-10-03 c2088c7a36db…2026-09-14 22:38:34 2026-08 N209279-001 8309126 2026-05-15 Drug product 2017-10-03 84e616aacf4f…2026-09-14 22:38:34 2026-08 N209279-001 7959945 2027-12-28 Drug product 2017-10-03 84e616aacf4f…2026-08-18 06:07:40 2026-07 N209279-001 8309126 2026-05-15 Drug product 2017-10-03 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N209279-001 7959945 2027-12-28 Drug product 2017-10-03 caaa826d4ba7…2026-02-19 14:30 UTC 2026-02 N209279-001 8309126 2026-05-15 Drug product 2017-10-03 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N209279-001 7959945 2027-12-28 Drug product 2017-10-03 011fe1cb6892…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N209279-001 8309126 2026-05-15 Drug product 2017-10-03 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N209279-001 7959945 2027-12-28 Drug product 2017-10-03 31067a03dcf5…2025-08-23 18:47 UTC 2025-08 N209279-001 8309126 2026-05-15 Drug product 2017-10-03 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 N209279-001 7959945 2027-12-28 Drug product 2017-10-03 6a471c1ec25d…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N209279-001 8309126 2026-05-15 Drug product 2017-10-03 fd3edfee7708…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N209279-001 7959945 2027-12-28 Drug product 2017-10-03 fd3edfee7708…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 N209279-001 8309126 2026-05-15 Drug product 2017-10-03 b8a1b40f171c…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 N209279-001 7959945 2027-12-28 Drug product 2017-10-03 b8a1b40f171c…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 N209279-001 8309126 2026-05-15 Drug product 2017-10-03 03ed91905a0d…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 N209279-001 7959945 2027-12-28 Drug product 2017-10-03 03ed91905a0d…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 N209279-001 8309126 2026-05-15 Drug product 2017-10-03 2680178bc6a6…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 N209279-001 7959945 2027-12-28 Drug product 2017-10-03 2680178bc6a6…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 N209279-001 8309126 2026-05-15 Drug product 2017-10-03 5bbf6a4d5a75…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 N209279-001 7959945 2027-12-28 Drug product 2017-10-03 5bbf6a4d5a75…2024-11-08 22:44 UTC · 3 captures of this ZIP 2024-11 N209279-001 8309126 2026-05-15 Drug product 2017-10-03 d8e5a09893c0…2024-11-08 22:44 UTC · 3 captures of this ZIP 2024-11 N209279-001 7959945 2027-12-28 Drug product 2017-10-03 d8e5a09893c0…2024-10-29 15:01 UTC 2024-10 N209279-001 8309126 2026-05-15 Drug product 2017-10-03 d06236e962d9…2024-10-29 15:01 UTC 2024-10 N209279-001 7959945 2027-12-28 Drug product 2017-10-03 d06236e962d9…2024-08-13 05:28 UTC · 3 captures of this ZIP 2024-08 N209279-001 8309126 2026-05-15 Drug product 2017-10-03 79d66fd596c7…2024-08-13 05:28 UTC · 3 captures of this ZIP 2024-08 N209279-001 7959945 2027-12-28 Drug product 2017-10-03 79d66fd596c7…2024-07-13 05:37 UTC · 2 captures of this ZIP 2024-07 N209279-001 8309126 2026-05-15 Drug product 2017-10-03 301d65b070ca…2024-07-13 05:37 UTC · 2 captures of this ZIP 2024-07 N209279-001 7959945 2027-12-28 Drug product 2017-10-03 301d65b070ca…2024-06-18 03:08 UTC · 5 captures of this ZIP 2024-06 N209279-001 8309126 2026-05-15 Drug product 2017-10-03 1e350fbaab3a…2024-06-18 03:08 UTC · 5 captures of this ZIP 2024-06 N209279-001 7959945 2027-12-28 Drug product 2017-10-03 1e350fbaab3a…2024-05-31 18:47 UTC 2024-05 N209279-001 8309126 2026-05-15 Drug product 2017-10-03 8072bd15b7f6…2024-05-31 18:47 UTC 2024-05 N209279-001 7959945 2027-12-28 Drug product 2017-10-03 8072bd15b7f6…2022-06-29 02:47 UTC · 2 captures of this ZIP 2022-06 N209279-001 8309126 2026-05-15 Drug product 2017-10-03 5c6f7cd8ea54…2022-06-29 02:47 UTC · 2 captures of this ZIP 2022-06 N209279-001 7959945 2027-12-28 Drug product 2017-10-03 5c6f7cd8ea54…2022-04-08 23:34 UTC 2022-04 N209279-001 8309126 2026-05-15 Drug product 2017-10-03 5d02ea3f76ae…2022-04-08 23:34 UTC 2022-04 N209279-001 7959945 2027-12-28 Drug product 2017-10-03 5d02ea3f76ae…2022-04-04 05:41 UTC 2022-04 N209279-001 8309126 2026-05-15 Drug product 2017-10-03 4b0b4de00fa7…2022-04-04 05:41 UTC 2022-04 N209279-001 7959945 2027-12-28 Drug product 2017-10-03 4b0b4de00fa7…
Observed Orange Book exclusivity history# Exclusivity history page 1 of 2 · 41 observed states.
openFDA label cross-check# OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
Matched openFDA labels page 1 of 1 · 1 matching rows.
Brand, Generic, Manufacturer table Brand Generic Manufacturer SPL set ID Effective date Available safety fields Join Tracleer BOSENTAN Actelion Pharmaceuticals US, Inc. 749e42fb-2fe0-45dd-9268-b43bb3f4081c 2025-11-17 Boxed warning, Warnings, Adverse reactions Exact identifier application applno (NDA): 209279 application number: NDA209279 ndc (product): 66215-232
Reported adverse events (FAERS/openFDA)# Adverse event summaries are temporarily unavailable. Other product information remains available.
NDC Listings For This Application# NDC listings for this application page 1 of 1 · 13 matching rows.
NDC, Name, Nonproprietary name table NDC Name Nonproprietary name Labeler Marketing category Status 66215-103 Tracleer bosentan Actelion Pharmaceuticals US, Inc. NDA Current 66215-103 Tracleer bosentan Actelion Pharmaceuticals US, Inc. NDA Current 66215-103 Tracleer bosentan Actelion Pharmaceuticals US, Inc. NDA Current 66215-103 Tracleer bosentan Actelion Pharmaceuticals US, Inc. NDA Current 66215-103 Tracleer bosentan Actelion Pharmaceuticals US, Inc. NDA Current 66215-103 Tracleer bosentan Actelion Pharmaceuticals US, Inc. NDA Current 66215-103 Tracleer bosentan Actelion Pharmaceuticals US, Inc. NDA Current 66215-103 Tracleer bosentan Actelion Pharmaceuticals US, Inc. NDA Current 66215-103 Tracleer bosentan Actelion Pharmaceuticals US, Inc. NDA Current 66215-232 Tracleer bosentan Actelion Pharmaceuticals US, Inc. NDA Current 66215-232 Tracleer bosentan Actelion Pharmaceuticals US, Inc. NDA Current 66215-232 Tracleer bosentan Actelion Pharmaceuticals US, Inc. NDA Current 66215-232 Tracleer bosentan Actelion Pharmaceuticals US, Inc. NDA Current